Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery

Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery

Objective: Nowadays, there were few studies reporting the risk stratification of patients with esophageal squamous cell carcinoma (ESCC) after neoadjuvant chemoradiation (NCRT) and surgery. We aimed to establish a simple risk stratification to help postoperative detection and adjuvant treatment. Met...

Full description

Bibliographic Details
Main Authors:	Ya-hua Wu, Ming-qiang Lin, Zhi-ping Wang, Jian-cheng Li
Format:	Article
Language:	English
Published:	Elsevier 2021-05-01
Series:	Translational Oncology
Subjects:	Neoadjuvant chemoradiation Esophageal squamous cell carcinoma Risk stratification Recurrence Adujvant treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523321000292

Similar Items

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
by: Stefan Münch, et al.
Published: (2019-04-01)

CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)
by: Han Tang, et al.
Published: (2017-06-01)

The Impact of Radiation to Epicardial Adipose Tissue on Prognosis of Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Esophagectomy
by: Hung-Chi Tai, et al.
Published: (2021-04-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
by: Tania Triantafyllou, et al.
Published: (2020-07-01)

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
by: Deepa M. Joseph, et al.
Published: (2021-09-01)

Change in Maximal Esophageal Wall Thickness Provides Prediction of Survival and Recurrence in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy and Surgery
by: Wu Y, et al.
Published: (2021-03-01)

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
by: Stefan Münch, et al.
Published: (2017-11-01)

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors
by: Han-Gil Kim, et al.
Published: (2021-01-01)

Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation
by: Hu Qiu, et al.
Published: (2021-09-01)

Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases
by: Yang Z, et al.
Published: (2016-07-01)

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-01-01)

Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Qingtao Qiu, et al.
Published: (2020-08-01)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
by: Dongryul Oh, et al.
Published: (2020-08-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Ding T, et al.
Published: (2021-10-01)

Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy
by: Yue Li, et al.
Published: (2021-02-01)

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
by: Rishi Jain, et al.
Published: (2020-10-01)

A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy
by: Xun Wu, et al.
Published: (2021-06-01)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2017-03-01)

Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma
by: Sachiyo Onishi, et al.
Published: (2020-09-01)

Bio-physic constraint model using spatial registration of delta 18F-fluorodeoxyglucose positron emission tomography/computed tomography images for predicting radiation pneumonitis in esophageal squamous cell carcinoma patients receiving neoadjuvant chemoradiation
by: Hou TC, et al.
Published: (2019-08-01)

Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma
by: Steven N. Seyedin, et al.
Published: (2020-07-01)

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer
by: Cleary, James M., et al.
Published: (2016)

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
by: Seiichi Nakaya, et al.
Published: (2021-07-01)

Preoperative Chemoradiation in Locally-Advanced Resectable Carcinoma of the Esophagus in a Single Rural Cancer Hospital in Western India
by: Yogesh S. Anap, et al.
Published: (2020-07-01)

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
by: Tarun Kumar, et al.
Published: (2020-03-01)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
by: Dueck Amylou C, et al.
Published: (2011-08-01)

Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)
by: Keijiro Sugimura, et al.
Published: (2021-01-01)

Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer
by: Kun-Yao Dai, et al.
Published: (2020-02-01)

Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trial
by: Liu Mina, et al.
Published: (2012-08-01)

Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments
by: Dongni Chen, et al.
Published: (2021-02-01)

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
by: Yusuke Sato, et al.
Published: (2021-02-01)

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
by: Xu Yaping, et al.
Published: (2012-08-01)

Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy
by: Mingrui Shao, et al.
Published: (2019-03-01)

Neoadjuvant chemoradiation with capcitabine and celecoxib in stage II and III rectal adenocarcinoma
by: Aghili M, et al.
Published: (2010-10-01)

Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
by: Fukuda, T., et al.
Published: (2022)

Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study
by: Guangyuan Liu, et al.
Published: (2019-05-01)

Complete remission of locally adComplete remission of locally advanced penile squamous cell carcinoma after multimodality treatment
by: Yifan Meng, et al.
Published: (2016-12-01)